| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WISH | Class A Common Stock | Conversion of derivative security | $0 | +1.19K | +7.56% | $0.00 | 17K | Aug 15, 2021 | Direct | F1 |
| transaction | WISH | Class A Common Stock | Options Exercise | $0 | +2.21K | +13.02% | $0.00 | 19.2K | Aug 15, 2021 | Direct | |
| transaction | WISH | Class A Common Stock | Sale | -$8.91K | -1.29K | -6.71% | $6.92 | 17.9K | Aug 16, 2021 | Direct | F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WISH | Restricted Stock Unit | Options Exercise | $0 | -300 | -3.96% | $0.00 | 7.28K | Aug 15, 2021 | Class B Common Stock | 300 | $0.00 | Direct | F4, F5 |
| transaction | WISH | Class B Common Stock | Options Exercise | $0 | +300 | $0.00 | 300 | Aug 15, 2021 | Class A Common Stock | 300 | Direct | F6, F7 | ||
| transaction | WISH | Restricted Stock Unit | Options Exercise | $0 | -310 | -5.56% | $0.00 | 5.27K | Aug 15, 2021 | Class B Common Stock | 310 | $0.00 | Direct | F4, F7 |
| transaction | WISH | Class B Common Stock | Options Exercise | $0 | +310 | +103.33% | $0.00 | 610 | Aug 15, 2021 | Class A Common Stock | 310 | Direct | F6, F7 | |
| transaction | WISH | Restricted Stock Unit | Options Exercise | $0 | -31 | -4.68% | $0.00 | 632 | Aug 15, 2021 | Class B Common Stock | 31 | $0.00 | Direct | F4, F8 |
| transaction | WISH | Class B Common Stock | Options Exercise | $0 | +31 | +5.08% | $0.00 | 641 | Aug 15, 2021 | Class A Common Stock | 31 | Direct | F6, F7 | |
| transaction | WISH | Restricted Stock Unit | Options Exercise | $0 | -553 | -2.63% | $0.00 | 20.5K | Aug 15, 2021 | Class B Common Stock | 553 | $0.00 | Direct | F4, F9 |
| transaction | WISH | Class B Common Stock | Options Exercise | $0 | +553 | +86.27% | $0.00 | 1.19K | Aug 15, 2021 | Class A Common Stock | 553 | Direct | F4, F6, F7 | |
| transaction | WISH | Class B Common Stock | Conversion of derivative security | $0 | -1.19K | -100% | $0.00* | 0 | Aug 15, 2021 | Class A Common Stock | 1.19K | Direct | F6, F7 | |
| transaction | WISH | Restricted Stock Unit | Options Exercise | $0 | -2.21K | -6.25% | $0.00 | 33.2K | Aug 15, 2021 | Class A Common Stock | 2.21K | $0.00 | Direct | F4, F10 |
| Id | Content |
|---|---|
| F1 | Represents the conversion of Class B Common Stock, issued upon settlement of vested Restricted Stock Units ("RSUs"), into Class A Common Stock held of record by the Reporting Person |
| F2 | The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholdings obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices with the range of $6.7510 to $6.9301, inclusive. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price with the range set forth in this footnote. |
| F4 | This reported transaction represents the settlement of RSUs vested as of August 15, 2021. |
| F5 | Each RSU represents a contingent right to receive one share of Issuer's Class B Common Stock. Subject to the reporting person's continued service, 20% of the RSUs vested on August 20, 2019, with 1/60th of the RSUs vesting monthly thereafter for a period of 4 years. |
| F6 | All shares of Class B Common Stock will automatically convert, on a one-for-one basis, into shares of Class A Common Stock on the earliest of (i) any transfer of the Class B Common Stock by the holder, whether or not for value, subject to certain exceptions, (ii) the 7-year anniversary of the closing sale of the issuer's initial public offering, (iii) the date on which the number of outstanding shares of Class B Common Stock represents less than 5% of the aggregate combined number of outstanding shares of Class A Common Stock and Class B Common Stock, (iv) the date specified by a vote of the holders of a majority of the then outstanding shares of Class B Common Stock, or (v) a date that is between 90 and 270 days, as determined by the board of directors, after the death or permanent incapacity of the issuer's founder, CEO, and Chairperson. |
| F7 | Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon any transfer, whether or not for value, except certain permitted transfers. |
| F8 | Each RSU represents a contingent right to receive one share of Issuer's Common B Stock. Subject to the reporting person's continued service, 1/48th of the RSUs vest monthly beginning on May 1, 2019 for a period of 4 years. |
| F9 | Each RSU represents a contingent right to receive on share of Issuer's Class B Common Stock. Subject to the reporting person's continued service, 25% of the RSUs vested on January 1, 2020, with 1/48th of the RSUs vesting monthly thereafter for a period of 3 years. |
| F10 | Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock. Subject to the reporting person's continuous service, 6.25% of the RSUs will vest on a quarterly basis beginning on August 15, 2021 (with all quarterly vesting events occurring on a "Company Vesting Date" of February 15, May 15, August 15, or November 15). Vested RSUs will settle on or following the vesting date, but in any event within 60 days following the vesting date (unless the Reporting Person and the Company have agreed in writing to a later settlement date pursuant to procedures the Company may prescribe at its discretion). |